• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Low Uptake of Long-Acting Injectables in the First 2.5 Years Following Approval Among a Cohort of People Living With HIV.

作者信息

Manghani Priyanka, Monroe Anne, Castel Amanda, Kumar Princy, Phunmongkol Jennifer, Denyer Rachel, O'Connor Lauren

机构信息

Department of Epidemiology, Milken Institute School of Public Health, George Washington University, Washington, DC, USA.

Division of Infectious Diseases, Georgetown University School of Medicine, Washington, DC, USA.

出版信息

Open Forum Infect Dis. 2024 May 16;11(5):ofae087. doi: 10.1093/ofid/ofae087. eCollection 2024 May.

DOI:10.1093/ofid/ofae087
PMID:38756764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11097117/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dc7/11097117/780f085cd31e/ofae087f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dc7/11097117/780f085cd31e/ofae087f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dc7/11097117/780f085cd31e/ofae087f1.jpg

相似文献

1
Low Uptake of Long-Acting Injectables in the First 2.5 Years Following Approval Among a Cohort of People Living With HIV.在一组艾滋病毒感染者中，长效注射剂获批后的头2.5年里使用率较低。
Open Forum Infect Dis. 2024 May 16;11(5):ofae087. doi: 10.1093/ofid/ofae087. eCollection 2024 May.
2
Provision of immediate postpartum contraception to women living with HIV in the Eastern Cape, South Africa; a cross-sectional analysis.南非东开普省为艾滋病毒感染者产妇提供即时产后避孕措施：一项横断面分析。
Reprod Health. 2020 Dec 9;17(1):194. doi: 10.1186/s12978-020-01049-9.
3
Characteristics of people on long-acting injectable antipsychotics in Australia: Data from the 2010 National Survey of High Impact Psychosis.澳大利亚长效注射抗精神病药物使用者的特征：来自 2010 年全国重度精神病影响调查的数据。
Aust N Z J Psychiatry. 2021 Oct;55(10):958-975. doi: 10.1177/00048674211009602. Epub 2021 Apr 27.
4
Long-Acting Injectables: Current Perspectives and Future Promise.长效注射剂：当前观点与未来前景
Crit Rev Ther Drug Carrier Syst. 2019;36(2):137-181. doi: 10.1615/CritRevTherDrugCarrierSyst.2018025649.
5
Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain.每两个月给药一次的卡博特韦和利匹韦林长效抗逆转录病毒疗法在西班牙治疗HIV-1具有成本效益。
Infect Dis Ther. 2023 Aug;12(8):2039-2055. doi: 10.1007/s40121-023-00840-y. Epub 2023 Jul 14.
6
Where are we with injectables against HIV infection and what are the remaining challenges?我们在抗 HIV 感染的注射剂方面进展如何，还有哪些挑战尚未解决？
Expert Rev Anti Infect Ther. 2018 Feb;16(2):143-152. doi: 10.1080/14787210.2018.1430570. Epub 2018 Jan 25.
7
Vaginal bleeding patterns in women using once-a-month injectable contraceptives.使用每月注射一次的避孕针剂的女性的阴道出血模式。
Contraception. 1994 Apr;49(4):399-420. doi: 10.1016/0010-7824(94)90035-3.
8
Long-Acting Injectable Cabotegravir and Rilpivirine in a Pregnant Woman With HIV.长效注射用卡博特韦和利匹韦林用于一名感染艾滋病毒的孕妇
Clin Infect Dis. 2024 Dec 17;79(6):1468-1471. doi: 10.1093/cid/ciae242.
9
Patient Education and Decision Support for Long-Acting Injectable HIV Antiretroviral Therapy: Protocol for Tool Development and Pilot Testing with Ryan White HIV/AIDS Program Medical Case Management Programs in New York.长效注射用抗逆转录病毒疗法的患者教育与决策支持：纽约州瑞安·怀特艾滋病病毒/艾滋病项目医疗病例管理项目的工具开发与试点测试方案
JMIR Res Protoc. 2024 Mar 27;13:e56892. doi: 10.2196/56892.
10
A New Level A Type IVIVC for the Rational Design of Clinical Trials Toward Regulatory Approval of Generic Polymeric Long-Acting Injectables.用于通用型聚合物长效注射剂监管批准的临床试验合理设计的新型 A 级体外-体内相关性模型
Clin Pharmacokinet. 2016 Oct;55(10):1179-1190. doi: 10.1007/s40262-016-0388-1.

引用本文的文献

1
Early Experience and Effectiveness of Long-Acting Injectable Cabotegravir and Rilpivirine in a South Side Chicago HIV Clinic.长效注射用卡博特韦和利匹韦林在芝加哥南区一家艾滋病诊所的早期经验及疗效
Open Forum Infect Dis. 2025 Feb 15;12(3):ofaf094. doi: 10.1093/ofid/ofaf094. eCollection 2025 Mar.

本文引用的文献

1
EquiPrEP: An implementation science protocol for promoting equitable access and uptake of long-acting injectable HIV pre-exposure prophylaxis (LAI-PrEP).EquiPrEP：促进长时效注射型 HIV 暴露前预防（LAI-PrEP）公平可及和使用的实施科学方案。
PLoS One. 2023 Sep 19;18(9):e0291657. doi: 10.1371/journal.pone.0291657. eCollection 2023.
2
Demonstration Project of Long-Acting Antiretroviral Therapy in a Diverse Population of People With HIV.长效抗逆转录病毒疗法在不同 HIV 人群中的示范项目。
Ann Intern Med. 2023 Jul;176(7):969-974. doi: 10.7326/M23-0788. Epub 2023 Jul 4.
3
Injectable Long-Acting Cabotegravir-Rilpivirine Therapy for People Living With HIV/AIDS: Addressing Implementation Barriers From the Start.
注射用长效卡替拉韦/利匹韦林治疗艾滋病毒/艾滋病患者：从一开始就解决实施障碍。
J Assoc Nurses AIDS Care. 2023;34(2):216-220. doi: 10.1097/JNC.0000000000000386. Epub 2023 Jan 20.
4
Perspectives on long-acting injectable HIV antiretroviral therapy at an alternative care site: a qualitative study of people with HIV experiencing substance use and/or housing instability.在替代护理点对长效注射型 HIV 抗逆转录病毒治疗的看法：一项对同时存在药物使用和/或住房不稳定问题的 HIV 感染者进行的定性研究。
Harm Reduct J. 2023 Jan 10;20(1):4. doi: 10.1186/s12954-023-00730-z.
5
Early Experience Implementing Long-Acting Injectable Cabotegravir/Rilpivirine for Human Immunodeficiency Virus-1 Treatment at a Ryan White-Funded Clinic in the US South.美国南部一家由瑞安·怀特基金资助的诊所实施长效注射用卡博特韦/利匹韦林治疗人类免疫缺陷病毒1型的早期经验。
Open Forum Infect Dis. 2022 Sep 2;9(9):ofac455. doi: 10.1093/ofid/ofac455. eCollection 2022 Sep.
6
A Patient Decision Aid (i.ARTs) to Facilitate Women's Choice Between Oral and Long-Acting Injectable Antiretroviral Treatment for HIV: Protocols for its Development and Randomized Controlled Pilot Trial.一种帮助女性在口服和长效注射用抗逆转录病毒疗法之间选择治疗HIV的患者决策辅助工具（i.ARTs）：其开发方案及随机对照试验。
JMIR Res Protoc. 2022 Sep 13;11(9):e35646. doi: 10.2196/35646.
7
Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine.长效注射治疗在 HIV 感染者中的应用：从精神病学和成瘾医学中汲取经验展望未来。
AIDS Behav. 2023 Jan;27(1):10-24. doi: 10.1007/s10461-022-03817-z. Epub 2022 Sep 5.
8
First Demonstration Project of Long-Acting Injectable Antiretroviral Therapy for Persons With and Without Detectable Human Immunodeficiency Virus (HIV) Viremia in an Urban HIV Clinic.长效注射型抗逆转录病毒疗法在城市 HIV 诊所中针对有/无症状 HIV 病毒血症患者的首次示范项目。
Clin Infect Dis. 2023 Feb 8;76(3):e645-e651. doi: 10.1093/cid/ciac631.
9
Are Patients and Their Providers Talking About Long-Acting Injectable Antiretroviral Therapy? Penetration into Clinical Encounters at Three U.S. Care Sites.患者及其医疗服务提供者是否在谈论长效注射抗逆转录病毒疗法？在美国三个医疗场所的临床诊疗中的普及情况。
Open Forum Infect Dis. 2022 Jun 11;9(7):ofac293. doi: 10.1093/ofid/ofac293. eCollection 2022 Jul.
10
Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir-rilpivirine in clinical practice.长效药物准备好了吗？长效卡替拉韦-利匹韦林在临床实践中的可行性评估。
J Med Virol. 2022 Oct;94(10):4970-4974. doi: 10.1002/jmv.27890. Epub 2022 Jun 9.